HCAT
Income statement / Annual
Last year (2024), Health Catalyst, Inc.'s total revenue was $306.58 M,
an increase of 3.60% from the previous year.
In 2024, Health Catalyst, Inc.'s net income was -$69.50 M.
See Health Catalyst, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
| Operating Revenue |
$306.58 M |
$295.94 M |
$276.24 M |
$241.93 M |
$188.85 M |
$154.94 M |
$112.57 M |
$73.08 M |
| Cost of Revenue |
$165.81 M
|
$164.11 M
|
$143.05 M
|
$124.35 M
|
$98.08 M
|
$75.35 M
|
$59.85 M
|
$43.64 M
|
| Gross Profit |
$140.78 M
|
$131.83 M
|
$133.19 M
|
$117.57 M
|
$90.77 M
|
$79.60 M
|
$52.72 M
|
$29.44 M
|
| Gross Profit Ratio |
0.46
|
0.45
|
0.48
|
0.49
|
0.48
|
0.51
|
0.47
|
0.4
|
| Research and Development Expenses |
$57.95 M
|
$72.63 M
|
$75.68 M
|
$62.73 M
|
$53.52 M
|
$46.25 M
|
$38.59 M
|
$28.47 M
|
| General & Administrative Expenses |
$56.82 M
|
$76.56 M
|
$61.70 M
|
$85.93 M
|
$59.24 M
|
$31.71 M
|
$22.69 M
|
$14.70 M
|
| Selling & Marketing Expenses |
$54.39 M
|
$67.32 M
|
$87.51 M
|
$75.03 M
|
$55.41 M
|
$47.28 M
|
$44.12 M
|
$25.92 M
|
| Selling, General & Administrative Expenses |
$111.20 M
|
$143.88 M
|
$149.22 M
|
$160.96 M
|
$114.65 M
|
$79.00 M
|
$66.81 M
|
$40.62 M
|
| Other Expenses |
$41.43 M
|
$42.22 M
|
$48.30 M
|
$37.53 M
|
$18.73 M
|
$9.21 M
|
-$39.00 K
|
-$4.00 K
|
| Operating Expenses |
$210.59 M
|
$258.73 M
|
$273.19 M
|
$261.22 M
|
$186.89 M
|
$134.46 M
|
$112.82 M
|
$74.98 M
|
| Cost And Expenses |
$376.39 M
|
$422.84 M
|
$416.24 M
|
$385.58 M
|
$284.97 M
|
$209.81 M
|
$172.67 M
|
$118.62 M
|
| Interest Income |
$17.98 M
|
$16.39 M
|
$5.69 M
|
$831.00 K
|
$2.09 M
|
$2.81 M
|
$602.00 K
|
$542.00 K
|
| Interest Expense |
$17.09 M
|
$7.29 M
|
$7.24 M
|
$17.31 M
|
$13.72 M
|
$6.26 M
|
$2.59 M
|
$2.01 M
|
| Depreciation & Amortization |
$41.43 M
|
$42.22 M
|
$51.53 M
|
$41.11 M
|
$18.73 M
|
$9.21 M
|
$7.41 M
|
$5.89 M
|
| EBITDA |
-$10.65 M |
-$68.28 M |
-$82.92 M |
-$101.68 M |
-$85.91 M |
-$47.32 M |
-$52.12 M |
-$39.75 M |
| EBITDA Ratio |
-0.03
|
-0.23
|
-0.3
|
-0.42
|
-0.45
|
-0.31
|
-0.46
|
-0.54
|
| Operating Income Ratio |
-0.23
|
-0.43
|
-0.51
|
-0.59
|
-0.51
|
-0.35
|
-0.53
|
-0.62
|
| Total Other Income/Expenses Net |
$637.00 K
|
$9.11 M
|
-$1.68 M
|
-$16.46 M
|
-$20.09 M
|
-$5.09 M
|
-$2.02 M
|
-$1.47 M
|
| Income Before Tax |
-$69.17 M
|
-$117.79 M
|
-$141.68 M
|
-$160.11 M
|
-$116.21 M
|
-$59.95 M
|
-$62.12 M
|
-$47.01 M
|
| Income Before Tax Ratio |
-0.23
|
-0.4
|
-0.51
|
-0.66
|
-0.62
|
-0.39
|
-0.55
|
-0.64
|
| Income Tax Expense |
$333.00 K
|
$356.00 K
|
-$4.28 M
|
-$6.90 M
|
-$1.19 M
|
$142.00 K
|
-$135.00 K
|
$26.00 K
|
| Net Income |
-$69.50 M
|
-$118.15 M
|
-$137.40 M
|
-$153.21 M
|
-$115.02 M
|
-$60.10 M
|
-$61.98 M
|
-$47.04 M
|
| Net Income Ratio |
-0.23
|
-0.4
|
-0.5
|
-0.63
|
-0.61
|
-0.39
|
-0.55
|
-0.64
|
| EPS |
-1.15 |
-2.09 |
-2.56 |
-3.23 |
-2.91 |
-3.21 |
-2.23 |
-1.69 |
| EPS Diluted |
-1.15 |
-2.09 |
-2.54 |
-3.23 |
-2.91 |
-3.21 |
-2.23 |
-1.69 |
| Weighted Average Shares Out |
$60.19 M
|
$56.42 M
|
$53.72 M
|
$47.49 M
|
$39.54 M
|
$18.74 M
|
$27.77 M
|
$27.77 M
|
| Weighted Average Shares Out Diluted |
$60.19 M
|
$56.42 M
|
$54.08 M
|
$47.49 M
|
$39.54 M
|
$18.74 M
|
$27.77 M
|
$27.77 M
|
| Link |
|
|
|
|
|
|
|
|
